Barinthus Biotherapeutics (BRNS) Tax Provisions (2021 - 2026)
Barinthus Biotherapeutics (BRNS) reported Tax Provisions of -$16000.0 for Q1 2026, up 27.27% on a YoY basis from -$12571.4 in Q1 2025, and up 71.93% quarter-over-quarter from -$57000.0 in Q4 2025.
Barinthus Biotherapeutics (BRNS) Tax Provisions (2021 - 2026) Analysis & Trends
Barinthus Biotherapeutics has reported Tax Provisions for 6 years, with the latest figure at -$16000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions rose 27.27% year-over-year to -$16000.0; the trailing twelve-month figure through Mar 2026 stood at -$169000.0 (down 482.76% YoY), and the FY2025 full-year result was -$175000.0, down 297.73% from the prior year.
- Tax Provisions for Q1 2026 stood at -$16000.0, up from -$57000.0 in the prior quarter.
- The five-year high for Tax Provisions was $3000.0 in Q4 2024, with the low at -$2.0 million in Q4 2022.
- Historically, Tax Provisions has averaged -$457705.9 across 5 years, with a median of -$71000.0 in 2025.
- Annual changes were most pronounced in 2022 — Tax Provisions slumped 9528.57% — and 2024, when it surged 100.37%.
- Barinthus Biotherapeutics' Tax Provisions stood at -$2.0 million in 2022, then surged by 59.39% to -$820000.0 in 2023, then jumped by 100.37% to $3000.0 in 2024, then sank by 2000.0% to -$57000.0 in 2025, then soared by 71.93% to -$16000.0 in 2026.
- The last three Tax Provisions figures came in at -$16000.0 (Q1 2026), -$57000.0 (Q4 2025), and -$71000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - | -16,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16,000.00 |
| Dec 31, 2025 | -57,000.00 |
| Sep 30, 2025 | -71,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Mar 31, 2025 | -22,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Mar 31, 2024 | -37,000.00 |
| Dec 31, 2023 | -820,000.00 |
| Sep 30, 2023 | -603,000.00 |
| Jun 30, 2023 | -1.14 Mn |
| Mar 31, 2023 | -516,000.00 |
| Dec 31, 2022 | -2.02 Mn |
| Sep 30, 2022 | -674,000.00 |
| Jun 30, 2022 | -915,000.00 |
| Mar 31, 2022 | -863,000.00 |
| Dec 31, 2021 | 32,000.00 |
| Sep 30, 2021 | -7,000.00 |
| Jun 30, 2021 | 12,000.00 |